Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore to Use €545K in Funding to Hire Software-Development, Sales Staff

NEW YORK (GenomeWeb) – Qlucore has received €545,000 (about $579,000) in funding from a rights issue and a development loan from Swedish regional development fund ALMI, which it will use to hire software development staff for its head office in Lund, Sweden and also to increase its sales force in the US.

"We are grateful to ALMI and the shareholders of Qlucore for supporting the growth ambitions of the firm's management," Carl-Johan Ivarsson, Qlucore's president, said in a statement. He added that the investment will "significantly enhance" the speed of Qlucore's continued growth particularly in the US market, which the company sees as key to its future success.

Qlucore began its days as a collaborative research project at Lund University in 2007. The company markets Qlucore Omics Explorer, software for visualizing, exploring, analyzing, and sharing omics datasets. The tool offers interactive 3D visualizations, statistical support, and streamlined workflows for analyzing multiple data types.

The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.